Tue, Dec 10, 2024
In the backdrop of tussle over the ownership of the NBFC entity Religare, RBI has given the go-ahead to the Burman family's open offer.
More >
Wed, Jan 24, 2024
The fair trade regulator allowed the four entities to acquire Religare's 5.27 per cent through stock market purchase and another 26 per cent through an open offer.
Thu, Oct 19, 2023
The company said defence costs for the litigation are expected to breach the materiality threshold in the near future.
Mon, Sep 25, 2023
The Burmans reserve the right to appoint directors to the board of Religare and require the company to implement changes in the management structure as determined by its board.
Thu, Mar 03, 2022
The stocks were up 4 per cent intraday on this news and settled at Rs 357 on the NSE, up over 2 per cent from the Wednesday closing price.
Mon, Mar 08, 2021
According to an Exclusive report of Zee Business, the Dabar's promoters Burman family will increase share in Religare and can also take the management control of Religare.
Wed, May 02, 2018
The bidding war for Fortis Healthcare doesn’t seem to end. Hero Enterprise Investment Office-Burman Family Office and Malaysian IHH Healthcare Berhad hiked their offers for the Gurugram-based hospital chain on Tuesday.
Fri, Apr 27, 2018
Minority shareholders of Fortis Healthcare, comprising nearly 50% of the company’s shareholding, will now have representation on the hospital’s Board. The names of three additional independent directors recommeded by them have received management’s invitation.
Thu, Apr 26, 2018
Manipal Health Enterprises (MHE), backed by TPG Capital, has further sweetened the deal for Fortis Healthcare, valuing its hospital business at Rs 6,322 crore.
Mon, Apr 23, 2018
The development follows the Fortis board forming an expert panel last week to evaluate binding offers and make the final recommendation by April 26. On April 18, Hero Enterprise Investment Office and Burman Family Office improved their binding offer with a proposal to invest Rs 1,500 crore directly at a valuation of Rs 161.6 per share, from the earlier Rs 1,250 crore
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
